Arca
Skip to content
Tools
Tools

Diflorasone Diacetate Ointment

Recall D-0599-2024, part of FDA recall event 94854. See Rising Pharma Holdings's company page.

Rising Pharma Holding, Inc. started this Class III drug recall on Jun 24, 2024 (voluntary: firm initiated); FDA lists it as ongoing.

  • Classification: Class III
  • Started: Jun 24, 2024
  • Status: Ongoing

Why It Was Recalled

Class III

Failed Impurities/Degradation Specifications: The impurity results at 12 months stability testing,did not conform to the specification limit.

Record

Product
Diflorasone Diacetate Ointment, USP, 0.05%, 60g tube, Rx only, Mfd. By: Lyne Laboratories, Inc., Brockton, MA 02301; Mfd. For: Rising Pharmaceuticals, Inc., East Brunswick, NJ 08816 NDC 64980-124-60
Quantity
868 tubes
Lots and codes
Lot #, DI2303B, Exp 12/31/2024
Distribution
Nationwide in the USA
Recalling firm
Rising Pharma Holding, Inc., East Brunswick, NJ, United States
How the firm notified
Letter
FDA classified
Jul 16, 2024

Rising Pharma Holding, Inc.'s Other Recalls

Newest first, one product per recall event; search them all

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.